Impact of race on BluePrint genomic subtyping in HER2+ breast cancer

Publication: ASCO 2023, Abstract #TPS621 Authors: Eric A. Brown1; Linsey P. Gold1; Carl R. Gray2; Douglas K. Marks3; Vibha T. Thomas4; Alfredo A. Santillan5; Cynthia Ma6; Ciera Singleton7; William Audeh7; on behalf of the FLEX Investigators Group 1. Comprehensive Breast Care, Troy, MI; 2. Utah Hem Onc, Ogden, UT; 3. Perlmutter Cancer Center, NYU Langone Health, New York, NY; 4. Texas Oncology-Flower Mound, Flower Mound, TX; 5. Texas Oncology PA, San Antonio, TX; 6. Washington University School of Medicine, St. Louis, MO; 7. Agendia Inc., Irvine, CA.

Read More
2024-03-07T10:44:18-08:00June 18th, 2023|Evidence, HER2-positive, Other, Racial Disparities|

Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients

  PUBLICATION: SABCS 2020 AUTHORS: Dipali Sharma, Lisa E. Blumencranz, Read More

2024-03-25T08:00:27-07:00December 29th, 2020|Evidence, Other, Racial Disparities|

Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients

PUBLICATION: SABCS 2020 AUTHORS: Margaret Chen, Ava Kwong, Carolyn Hendricks, Read More

2024-03-25T08:02:55-07:00December 29th, 2020|Evidence, Other, Racial Disparities|

Genomic Profiling of Breast Cancer in African-American Women Using MammaPrint.

PUBLICATION: Breast Cancer Res Treat (2016) 159: 481. https://doi.org/10.1007/s10549-016-3949-y09. AUTHORS: Read More

2024-03-25T09:17:41-07:00August 27th, 2016|Evidence, MammaPrint, Other, Racial Disparities|
Go to Top